Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells

Cytokine

Volumn 36, Issue 5-6, 2006, Pages 237-244

  Abonyo, Barack O ^a   Lebby, Kimberly D ^a   Tonry, Jessica H ^a,b   Ahmad, Munir ^a   Heiman, Ann S ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b HAWAII BIOTECH INC   (United States)

Author keywords

Alveolar epithelial cells; CCL3; CCR3 receptors; CCR5 receptors; Eotaxins

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; EOTAXIN; EOTAXIN 2; EOTAXIN 3; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIOID CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL TYPE 2; MODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELL LINE, TUMOR; CHEMOKINES, CC; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-4; PULMONARY ALVEOLI; RECEPTORS, CCR5;

EID: 34047178932     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.01.001     Document Type: Article

References (36)

1. Cohn L., Elias J.A., and Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22 (2004) 789-815
2. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 38 (2001) 881-885
3. Elias J.A., Kang M.J., Crouthers K., Homer R., and Lee C.G. Mechanistic heterogeneity in chronic obstructive pulmonary disease. Insights from transgenic mice. Proc Am Thorac Soc 3 (2006) 494-498
4. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., et al. International union of pharmacology. XXII. Nomenclature for chemokines receptors. Pharmacol Rev 52 (2000) 145-176
5. Bacon K., Baggiolini M., Broxmeyer H., Horuk R., Lindley I., Mantovani A., et al. Chemokine/chemokines receptor nomenclature. J Interferon Cytokine Res 22 (2002) 1067-1068
6. Witherden I.R., Vanden Bon E.J., Goldstraw P., Ratcliffe C., Pastorino U., and Tetley T.D. Primary human alveolar type II epithelial cell chemokine release - Effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 30 (2004) 500-509
7. Abonyo B., Alexander M.S., and Heiman A.S. Autoregulation of CCL26 synthesis and secretion in A549 cells: A possible mechanism by which alveolar epithelial cells modulate airway inflammation. Am J Physiol Lung Cell Mol Physiol 289 (2005) L478-L488
8. Heiman A.S., Abonyo B.O., Darling-Reed S.F., and Alexander M.S. Cytokine-stimulated human lung alveolar epithelial cells release eotaxins-2 (CCL24) and eotaxins-3 (CCL26). J Interferon Cytokine Res 25 (2005) 82-91
9. Maurer M., and von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36 (2004) 1882-1886
10. Rot A., and von Andrian U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu Rev Immunol 22 (2004) 891-928
11. Ying S., Meng Q., Zeibecoglou K., Robinson D.S., Macfarlane A., Humbert M., et al. Eosinophil chemotactic cytokines (eotaxin, eotaxin-2, RANTES, monocytes chemoattractant protein-3 (MCP-3), and MCP-4, and CC chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 163 (1999) 6321-6329
12. Stellato C., Brummet M.E., Plitt J.R., Shahabuddin S., Baroody F.M., Liu M.C., et al. Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells. J Immunol 166 (2001) 1457-1461
13. Garcia G., Godot V., and Humbert M. New chemokine targets for asthma therapy. Curr Allergy Asthma Rep 5 (2005) 155-160
14. Barber C.G. CCR5 antagonists for the treatment of HIV. Curr Opin Investig Drugs 5 (2004) 851-861
15. Oppermann M. Chemokine receptor CCR5: insights into structure, function, and regulation. Cell Signal 16 (2004) 1201-1210
16. de Lavareille A., Roufosse F., Schandene L., Stordeur P., Cogan E., and Goldman M. Clonal Th2 cells associated with chronic hypereosinophilia. TARC-induced CCR4 down-regulation in vivo. Eur J Immunol 1 (2001) 1037-1046
17. Ma B., Kang M.-J., Lee C.G., Chapoval S., Liu W., Chen Q., et al. Role of CCR5 in IFN-γ-induced and cigarette-smoke-induced emphysema. J Clin Invest 115 (2005) 3460-3472
18. Blanpain C., Migeotte I., Lee B., Vakili J., Doranz B.J., Govaerts C., et al. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94 (1999) 1899-1905
19. Holgate S.T., Bodey K.S., Janezic A., Frew A.J., Kaplan A.P., and Teran L.M. Release of RANTES, MIP-1α, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 156 (1997) 1377-1383
20. Lim S., John M., Seybold J., Taylor D., Witt C., Barnes P.J., et al. Increased interleukin-10 and macrophage inflammatory protein-1 alpha release from blood monocytes ex vivo during late-phase response to allergen in asthma. Allergy 55 (2000) 489-495
21. Petkovic V., Moghini C., Paoletti S., Uguccioni M., and Gerber B. Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5 A human chemokine with a regulatory role. J Biol Chem 279 (2004) 23357-23363
22. White J.R., Imburgia C., Dul E., Appelbaum E., O'Donnell K., O'Shannessy D.J., et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 62 (1997) 667-675
23. Shinkai A., Yoshisue H., Koike M., Shoji E., Nakagawa S., Saito A., et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163 (1999) 1602-1610
24. Chvatchko Y., Proudfoot A.E., Buser R., Juillard P., Alouani S., Kosco-Vibois M., et al. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3. J Immunol 171 (2003) 5498-5506
25. Olszewska-Pazdrak B., Casola A., Saito T., Alam R., Crowe S.E., Mei F., et al. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 72 (1998) 4756-4764
26. Zhang Y., Luxon B.A., Casola A., Garofal R.P., Jamaluddin M., and Brasier A.R. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 75 (2001) 9044-9058
27. Lee B., Sharron M., Blanpain C., Doranz B.J., Vakili J., Setoh P., et al. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem 274 (1999) 9617-9626
28. Komiya A., Nagase H., Yamada H., Sekiya T., Yamaguchi M., Sano Y., et al. Concerted expression of eotaxin-1, eotaxin-2 and eotaxin-3 in human bronchial epithelial cells. Cell Immunol 225 (2003) 91-100
29. Kobayashi I., Yamamoto S., Nishi N., Tsuji K., Imayosh I.M., and Inada S. Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor-kappaB. Ann Allergy Asthma Immunol 93 (2004) 390-397
30. Yamamoto S., Lobayashi I., Tsuji K., Nishi N., Muro E., Miyazaki M., et al. Upregulation of interleukin-4 receptor by interferon-γ: enhanced interleukin-4-induced eotaxin-3 production in airway epithelium. Am J Respir Cell Mol Biol 31 (2004) 456-462
31. Berkman N., Ohnona S., Chung F.K., and Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 24 (2001) 682-687
32. Ravensberg A.J., Ricciardolo F.L.M., Van Schadewijk A., Rabe K.F., Sterk P.J., and Hiemstra P.S. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol 115 (2005) 779-785
33. Beck L.A., Tancowny B., Brummet M.E., Asaki S.Y., Curry S.L., Penno M.B., et al. Functional analysis of the chemokine receptor CCR3 on airway epithelial cells. J Immunol 177 (2006) 3344-3354
34. Tetley T.D. Inflammatory cells and chronic obstructive pulmonary disease. Current Drug Targets - Inflammat Allergy 4 (2005) 607-618
35. Grumelli S., Corry D.B., Song L.-Z., Green L., Huh J., Hacken J., et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 1 (2004) 75-83
36. Wang Z., Zheng T., Zhu Z., Homer R.J., Riese R.J., Chapman H.A., et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192 (2000) 1587-1600